a-virion_logo-footer

Alpha Virion is our proprietary anti pathogenic nanotechnology (patent pending GB 2016813.4, 22 October 2020) which is incorporated into the anti-viral copper layer of Pro-Larva. It is based on research carried out at Nottingham Trent University’s School of Science and Technology.

A-virion™ Alpha- Virion layer created a revolutionary virus-killing mask known as Pro-Larva deployed into the PPE market to create the world’s first covid and influenza-killing face mask this technology can be applied to any Face mask in the market.

A -virion™ layer in Pro-Larva has been certified to ISO 18184:2019 – a standard protocol to quantify the antiviral properties of textile materials, and can be readily incorporated in Type IIR medical masks (certified to EN14683:2019 standards). Copper is known to kill viruses, including COVID-19. Our copper nanoparticles create a larger surface area and have been independently tested to ensure they remain within the mask for maximum efficacy and safety for the wearer. On contact with the virus, the nanoparticles emit ions that penetrate the surface of the virus, destroying its genetic material preventing it from reproducing. This nanoparticle layer within the mask ensures enhanced protection compared to equivalent type II masks, for both the wearer and those in proximity.

Contact Us

General Contact
info@pharm2farm.org

Sales
sales@pharm2farm.org

Phone
+44 (0) 333 358 0478

To test materials to this standard, a specific concentration of virus is coated onto test and reference material. Following incubation at room temperature for seven hours, the samples are washed, and the amount of live virus left in the suspension is quantified using a TCID50 assay.